Repligen Corporation (1RGEN)
MTA
154.90
+0.25 (+0.16%)
Closed
Aug 24, 2026
Day's Range
152.65154.90
52 wk Range
96.34159.25
Financial Statements - 1RGEN - Repligen Corporation
Revenue
738.25M▲ 37.4%
Net Income
48.89M▲ 326.4%Net Margin 6.6%
EBITDA
139.67M▲ 246.4%
Free Cash Flow
91.68M▼ 24.0%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 738.25M | 537.11M |
| Cost of Goods | 352.01M | 304.60M |
| Gross Profit | 386.24M | 232.51M |
 Operating Expense | - | - |
| Operating Income | 41.56M | -27.02M |
| Non-Operating Interest | - | - |
| Other Income Expense | 43.99M | 23.24M |
| Pre Tax Income | 62.38M | -22.88M |
| Income Tax | 13.48M | -1.28M |
| Net Income | 48.89M | -21.60M |
| EPS Basic | 0.87 | -0.46 |
| EPS Diluted | 0.86 | -0.46 |
| Basic Shares Outstanding | 56.23M | 47.35M |
| Diluted Shares Outstanding | 56.23M | 47.35M |
| Ebit | 83.89M | -5.33M |
| Ebitda | 139.67M | 40.31M |
| Net Income Continuous Operations | 48.89M | -21.60M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
